Posted by Michael Wonder on 10 Sep 2017
New breast cancer drug could buy Greerton woman time
9 September 2017 - Bay woman Margaret Richardson has been told she will eventually lose her battle with cancer.
However, her dying wish is to live long enough to see her grandson grow up and to see her daughter walk down the aisle. She believes a new breast cancer drug may help prolong her life but she cannot afford the estimated cost of $5000 per month.
MedSafe NZ has approved the use of a breakthrough drug called palbociclib, or Ibrance, for people with advanced hormone receptor positive and HER2-negative breast cancer.
